Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 43c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.20), $0.43 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $238 thousand versus the consensus estimate of $56.34 million.

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
• HSBC Upgrades YPF S.A. (YPF) to Buy